Mehmet Samur

Also affiliated with Dana-Farber/Harvard Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 39 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer

JCI Insight(2020)10.1172/jci.insight.129353

N/A

2.2DataRank · unranked

62 citations

Federica Costa, Rituparna Das, Alyssa Duffy, Mehmet Samur, Samuel S. McCachren +17 more

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Blood(2020)10.1182/blood.2019004332

N/A

0DataRank · unranked

89 citations

Jiye Liu, Hiroto Ohguchi, Keiji Kurata, Mehmet Samur, Yu‐Tzu Tai +5 more

YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma

Blood(2020)10.1182/blood.2019004147

N/A

0DataRank · unranked

27 citations

Mariateresa Fulciniti, Mehmet Samur, Matthew Ho, Shuhui Deng, Lanting Liu +20 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Integrated genomics and comprehensive validation reveal novel drivers of genomic evolution in esophageal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.23.058230

N/A

0DataRank · unranked

0 citations

Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao +9 more

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature Communications(2021)10.1038/s41467-021-21177-5

N/A

0DataRank · unranked

414 citations

Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala +10 more

Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0047

N/A

0DataRank · unranked

139 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma

Blood Cancer Journal(2021)10.1038/s41408-021-00554-9

N/A

0DataRank · unranked

48 citations

Mehmet Samur, Leutz Buon, Subodh Kumar, Lakshmi B. Potluri, Jialan Shi +4 more

Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0108

N/A

0DataRank · unranked

40 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

Science Advances(2021)10.1126/sciadv.abg2697

N/A

0DataRank · unranked

26 citations

Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Samur +15 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

Blood Cancer Journal(2021)10.1038/s41408-020-00398-9

N/A

0DataRank · unranked

12 citations

Ting Du, Arghya Ray, Krishan Chauhan, Mehmet Samur, Nikhil C. Munshi +3 more

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

Haematologica(2021)10.3324/haematol.2021.279276

N/A

0DataRank · unranked

10 citations

Claudia Martinuzzi, Pamela Becherini, Elisa Gelli, Samantha Ruberti, Katia Todoerti +20 more

Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma

Communications Biology(2021)10.1038/s42003-021-02125-x

N/A

0DataRank · unranked

12 citations

Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao +9 more

Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.08.471297

N/A

0DataRank · unranked

0 citations

Mariateresa Fulciniti, Mehmet Samur, Caroline F. Ribeiro, León Wert-Lamas, Jon E. Henninger +27 more

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Nature Communications(2022)10.1038/s41467-022-28266-z

N/A

0DataRank · unranked

69 citations

Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson +19 more

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

Journal of Clinical Oncology(2022)10.1200/jco.21.01987

N/A

0DataRank · unranked

45 citations

Mehmet Samur, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel +17 more

Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

Haematologica(2022)10.3324/haematol.2021.279360

N/A

0DataRank · unranked

29 citations

Nagarajan Paramasivam, Umut H. Toprak, Daniel Hüebschmann, Jing Xu, Sebastian Uhrig +14 more

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

Blood Cancer Journal(2022)10.1038/s41408-022-00759-6

N/A

0DataRank · unranked

25 citations

Mariateresa Fulciniti, Hervé Avet‐Loiseau, Michael Lopez, Sanika Derebail, Jill Corre +8 more

ABL1 Kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491727

N/A

0DataRank · unranked

0 citations

Srikanth Talluri, Jiangning Zhao, Chengcheng Liao, Lakshmi B. Potluri, Leutz Buon +8 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3668

N/A

0DataRank · unranked

33 citations

Mehmet Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu +7 more

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

Blood(2023)10.1182/blood.2022017897

N/A

0DataRank · unranked

20 citations

Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet Samur +11 more

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00787-w

N/A

0DataRank · unranked

17 citations

Anna James-Bott, Mark A. Tye, Leona Yamamoto, Mehmet Samur, Yu‐Tzu Tai +24 more

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

Gastroenterology(2023)10.1053/j.gastro.2023.04.035

N/A

0DataRank · unranked

17 citations

Jiangning Zhao, Srikanth Talluri, Leutz Buon, Shidai Mu, Lakshmi B. Potluri +12 more

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Frontiers in Oncology(2023)10.3389/fonc.2023.1271807

N/A

0DataRank · unranked

10 citations

William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso +18 more

Investigation into aberrant B cell repertoire in myeloma on humoral immunity and patient survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8016

N/A

0DataRank · unranked

2 citations

Hannah Seah, Vaishnavi Reddy Bade, Arthur Krogman, Shree Acharya, Andreea Negroiu +13 more

Data from Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

(2023)10.1158/2643-3230.c.6550306

N/A

0DataRank · unranked

0 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Data from Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

(2023)10.1158/2643-3230.c.6550489.v1

N/A

0DataRank · unranked

0 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes

Nature Communications(2024)10.1038/s41467-024-47793-5

N/A

0DataRank · unranked

24 citations

Raphaël Szalat, Srikanth Talluri, Mariateresa Fulciniti, Hervé Avet‐Loiseau, Giovanni Parmigiani +3 more

Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

Blood(2024)10.1182/blood.2023022777

N/A

0DataRank · unranked

19 citations

Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Samur, Cirino Botta +24 more

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

Blood Advances(2024)10.1182/bloodadvances.2023012298

N/A

0DataRank · unranked

4 citations

Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martín, Madhumouli Chatterjee +15 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Blood(2025)10.1182/blood.2025028963

N/A

0DataRank · unranked

8 citations

Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, Jee Eun Choi +14 more

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Blood(2025)10.1182/blood.2025028746

N/A

0DataRank · unranked

5 citations

Anıl Aktaş Samur, Domenico Maisano, Claire Gao, Vanessa Favasuli, Dimitrios Papaioannou +17 more

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Nature Communications(2020)10.1038/s41467-019-14219-6

N/A

0DataRank · unranked

195 citations

Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean P. Pitroda, Mark D. Long +18 more

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0205

N/A

0DataRank · unranked

0 citations

William Pilcher, Marina E. Michaud, Chaitanya R. Acharya, Sarthak Satpathy, Edgar Gonzalez‐Kozlova +31 more

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Blood Advances(2020)10.1182/bloodadvances.2020002827

N/A

0DataRank · unranked

416 citations

Hervé Avet‐Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur +11 more